Standardised Derivatives


On January 18, 2016 Nasdaq Nordic launched standardised derivatives on Frontline, Genmab and Swedish Orphan Biovitrum



Frontline Ltd is an international shipping company. The Company operates in the tanker market as an international provider of seaborne transportation of crude oil.


Genmab A/S is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

Swedish Orphan Biovitrum

Swedish Orphan Biovitrum AB is an international specialty healthcare company dedicated to rare diseases.


On September 1, 2015 Nasdaq Nordic launched standardised derivatives on Betsson, BillerudKorsnäs and Fingerprint Cards.



Betsson AB invests, develops and operates on-line internet gaming companies. The Company through its subsidiaries conducts gaming operations over the Internet.  


BillerudKorsnas AB manufactures pulp and paper products. The Company develops and offers materials made from primary fibre and smart packaging solutions for the food and beverage, industrial, consumer and luxury goods, and medical and hygiene industries.

Fingerprint Cards AB

Fingerprint Cards AB develops, produces and markets fingerprint sensors with software that through the analysis and matching of an individual’s unique fingerprint verifies the person’s identity and permits secure and comfortable handling by the user.